🔎 Trials Near Me

Dachaigh › Sarcoma fighe bog › New York

Sgrùdaidhean clionaigeach Sarcoma fighe bog ann an New York

Tha 27 sgrùdaidhean airson Sarcoma fighe bog a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06942442

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Queens Hospital Center, Jamaica
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Stony Brook University Medical Center, Stony Brook
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Study of CRD3874-SI in People With Solid Tumors

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06021626

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06797999

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • New York University Langone Health, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05732831

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT04577014

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 12 gu 85 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT03715933

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06644755

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

  • Montefiore Medical Center, The Bronx
A’ fastadhÌre 1/2
Aoisean 12 gu 40 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07725380

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT05837767

Actinium Therapy for Late-stage Aggressive Sarcomas

  • Memorial Sloane Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07156565

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  • Northwell Health Cancer Institute, Lake Success
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT06975293

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

  • Roswell Park Cancer Institute, Buffalo
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT03965234

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06242470

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
  • Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT00579566

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07089992

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

  • Zai Lab Site 02002, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Iuch 2026 · NCT07374848

Integrated Cancer Repository for Cancer Research

  • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
  • Faxton St. Luke's Healthcare, Mohawk Valley, Utica
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
  • agus 1 a bharrachd
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Cèit 2026 · NCT06129903

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT04332874

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

  • Roswell Park Comprehensive Cancer Center, Buffalo
A’ fastadhSgrùdadh amharc
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT07402577

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

  • Memorial Sloan Kettering Cancer Centre, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT05755113

Phase II Trial of Lung Chemoemobolization

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT05672108

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
  • New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
A’ fastadhÌre 1/2
12 Months – 40 Years · Gach gnè · Air ùrachadh 5 Gearr 2026 · NCT03465592

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 2 gu 30 · Gach gnè · Air ùrachadh 3 Gearr 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital at Montefiore, The Bronx
A’ fastadhÌre 2
18 Months – 40 Years · Gach gnè · Air ùrachadh 12 Lùna 2025 · NCT05135975

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.